Rep. Levin Sends Letter Asking About the Rapid Price Increases for Opioid Overdose Reversal Medication

Mar 1, 2017

After the price for Evzio increased over 600% from $690 in 2014 for a two pack to $4,500, Rep. Levin joined 71 members of Congress in sending a letter to Kaléo Pharmaceuticals requesting more information on this rapid price increase.  Evzio is a naloxone auto-injector device, allowing people without medical training to administer life-saving naloxone to reverse the effects of a life-threatening opioid overdose.

Democrats Join Forces to Force a Vote on Trump's Ethics Violations
Rep. Levin joined fellow Democrats in cosponsoring a Resolution of Inquiry directing the Department of Justice to provide the House of Representatives with information relevant to an inquiry into President Trump's potential conflict of interest dealings and ethics violations.  If the Republican majority does not take up the Resolution in committee within 14 days, Democrats can then force a vote on the Resolution on the House Floor.

Administration Issues Concerning Executive Order to Weaken Financial Regulatory Reform
On February 3, the president signed an executive order designed to scale back and chip away at the critical financial reforms included in the Dodd-Frank Wall Street Reform and Consumer Protection Act.  Rep. Levin supported Dodd-Frank when it passed in 2010.  Dodd-Frank included important provisions to increase oversight, rein in abusive and excessively risky practices, and reduce the fragility of systemic risk that could again jeopardize the health of the financial system and financial security of the American people.  For example, under Dodd-Frank, the Commodity Futures Trading Commission (CFTC) is charged with ensuring transparency and oversight of the derivatives markets.  The law also created the Consumer Financial Protection Bureau.  The administration's executive order will result in the weakening of critical financial regulations and protections, and expose taxpayers to the risky landscape that led us to the financial crisis in 2008.

March is Women's History Month
In 1987, Congress enacted a law officially designating March as Women's History Month.  Each year, presidents, both Democrat and Republican, have issued proclamations honoring Women's History Month.  You can find more information here. The website includes digital photographs, historic newspapers, excerpts on women in government, and much more.  As we go through the month of March, let us take time to celebrate and honor the indispensable role of women in shaping and influencing American history.


On the Floor of the U.S. House this week:
The Republican Majority has scheduled legislation for consideration this week that will bring the regulatory process to halt, create uncertainty, and compromise public health and safety.
The House will debate the SCRUB Act (H.R. 998), a bill that would create an un-elected commission to recommend regulations for repeal and requires the cost of a new regulation to be offset by the repeal of older regulations.  We will also consider legislation (H.R. 1009) that would subject rulemakings by independent agencies to White House review, chipping away at their ability to implement policies without political interference.  Finally, the House will debate the Regulatory Integrity Act (H.R. 1004), which could prevent agencies from providing information or easy-to-understand summaries on proposed regulatory actions, and H.J. Res. 83, a resolution of disapproval on a rule issued by the Department of Labor regarding recordkeeping of workplace injuries and illnesses.